Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan.
Oncology Center, Yamaguchi University Hospital, Ube, Japan.
Surg Endosc. 2018 Apr;32(4):1945-1953. doi: 10.1007/s00464-017-5888-z. Epub 2017 Oct 26.
In this study, cytokine levels, outcome, and survival rates after esophagectomy for esophageal cancer were retrospectively investigated in a propensity score-matched comparison of operative approaches between the thoracoscopic esophagectomy (TE) in the prone position and open esophagectomy (OE).
Between 2005 and 2014, TE was performed on a group of 85 patients, which was compared with a group of 104 OE cases. Eventually, 65 paired cases were matched using propensity score matching.
Although the TE group underwent a significantly longer operation time than the OE group (P < 0.001), the TE group exhibited less blood loss (P < 0.001) and had a shorter postoperative hospital stay (P = 0.038) than the OE group. The serum interleukin-6 levels on ICU admission (P < 0.001) and on POD 1 (P < 0.001) were significantly lower in the TE group. The interleukin-10 levels on ICU admission (P < 0.001), POD 1 (P = 0.016), and POD 3 (P < 0.001) were also significantly lower in the TE group. Pulmonary complication was significantly lower in the TE group (P = 0.043). The 5-year PFS rates in the TE and OE groups were 70.6 and 58.7% (P = 0.328), respectively, and OS rates were 64.9 and 50.2% (P = 0.101), respectively.
TE compared to OE is a less invasive procedure with lower surgical stress and less pulmonary complication for the treatment of esophageal squamous cell carcinoma.
本研究回顾性分析了经胸腹腔镜食管切除术(TE)与开放食管切除术(OE)治疗食管癌的围手术期细胞因子水平、预后和生存率,并对两种手术方式进行了倾向评分匹配比较。
2005 年至 2014 年间,85 例患者接受 TE 治疗,与 104 例 OE 患者进行比较。最终,通过倾向评分匹配,将 65 对病例进行匹配。
尽管 TE 组的手术时间明显长于 OE 组(P<0.001),但 TE 组术中出血量较少(P<0.001),术后住院时间较短(P=0.038)。TE 组患者 ICU 入院时(P<0.001)和术后第 1 天(P<0.001)的血清白细胞介素-6 水平显著降低。TE 组患者 ICU 入院时(P<0.001)、术后第 1 天(P=0.016)和第 3 天(P<0.001)的白细胞介素-10 水平也显著降低。TE 组肺部并发症发生率较低(P=0.043)。TE 组和 OE 组的 5 年无进展生存率分别为 70.6%和 58.7%(P=0.328),总生存率分别为 64.9%和 50.2%(P=0.101)。
与 OE 相比,TE 是一种侵袭性较小的手术方式,可降低手术应激,减少肺部并发症,用于治疗食管鳞状细胞癌。